Table 5.
Multivariate analysis for the risk of death
| OR (95% CI)* | ||
|---|---|---|
|
| ||
| Crude | Adjusted& | |
| Sex (female-male) | 1.62 (0.50-5.24) | 1.41 (0.23-8.68) |
| Age | 1.03 (0.99-1.06) | 1.05 (0.98-1.13) |
| Cancer type (solid to nonsolid) | 1.87 (0.45-7.68) | 0.57 (0.04-6.9) |
| Comorbidity# | 0.58 (0.14-2.33) | 0.09 (0.00-2.47) |
| NLR | 1.05 (0.97-1.14) | 1.02 (0.87-1.19) |
| INR | 9.1 (0.79-105.1) | 6.52 (0.37-114.8) |
| Chemotherapy | ||
| 0 | 1 | 1 |
| 1 | 0.47 (0.11-2.0) | 0.72 (0.04-12.33) |
| 2 | 0.5 (0.04-5.7) | 3.12 (0.08-115.3) |
| 12 | 0.8 (0.16-3.9) | 4.92 (0.20-115.5) |
*The odds ratio, calculated with logistic regression, was considered significant if P<0.05, # At least had one of diseases (diabetes, chronic cardio vascular, chronic lung disease, hypertension), & All variable included in the adjusted logistic regression. NLR=Neutrophil to lymphocyte ratio; INR=International normalized ratio